EUROPE DIGITAL POLYMERASE CHAIN REACTION MARKET FORECAST 2107-2025
KEY FINDINGS
The Europe digital PCR market was valued $71 million in the year 2016. The market is expected to grow at a CAGR of 31.42% over the forecast period of 2017-2025 and generate $901 million by the end of 2025.
MARKET INSIGHTS
The European market is mainly divided into three segments: the products and services, the end-users, and the applications. The products and service segment is sub segmented into software solutions, reagents and consumables and instruments. Of these, the instruments segment is the most popular. The end-users comprise of forensic laboratories, clinical research laboratories, biotech and pharma companies, etc and the market finds its application in clinical studies, research, and forensics. In spite of such a wide scope, the market is under a threat from challenges such as the implementation of MIQE guidelines for publishing any dPCR-based research and the increasing availability of alternative technologies.
COMPETITIVE INSIGHTS
Some of the prominent companies in the market are: F. Hoffman-La Roche Ltd, Bio-Rad Laboratories, Inc, Fluidigm Corporation, Qiagen N.V, Gennova Scientific Sl, Thermo Fisher Scientific Inc, Raindance Technologies, Inc. (Acquired By Bio-Rad Laboratories, Inc), etc.
The Europe digital PCR market was valued $71 million in the year 2016. The market is expected to grow at a CAGR of 31.42% over the forecast period of 2017-2025 and generate $901 million by the end of 2025.
MARKET INSIGHTS
The European market is mainly divided into three segments: the products and services, the end-users, and the applications. The products and service segment is sub segmented into software solutions, reagents and consumables and instruments. Of these, the instruments segment is the most popular. The end-users comprise of forensic laboratories, clinical research laboratories, biotech and pharma companies, etc and the market finds its application in clinical studies, research, and forensics. In spite of such a wide scope, the market is under a threat from challenges such as the implementation of MIQE guidelines for publishing any dPCR-based research and the increasing availability of alternative technologies.
COMPETITIVE INSIGHTS
Some of the prominent companies in the market are: F. Hoffman-La Roche Ltd, Bio-Rad Laboratories, Inc, Fluidigm Corporation, Qiagen N.V, Gennova Scientific Sl, Thermo Fisher Scientific Inc, Raindance Technologies, Inc. (Acquired By Bio-Rad Laboratories, Inc), etc.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
4. MARKET DYNAMICS
4.1. DRIVERS
4.1.1. INCREASING INCIDENTS OF INFECTIOUS DISEASES AND GENETIC DISORDERS
4.1.2. INCREASING ELDERLY POPULATION
4.1.3. RISING GERIATRIC POPULATION
4.1.4. INCREASING PUBLIC–PRIVATE INVESTMENTS AND GRANTS
4.1.5. RISE IN THE NUMBER OF HOSPITALS AND DIAGNOSTICS CENTERS
4.2. RESTRAINTS
4.2.1. HIGH DEVICE COSTS ASSOCIATED WITH DPCR
4.2.2. NEED TO TRAINING AND UPDATATION OF LABORATORIES WORKERS
4.3. OPPORTUNITIES
4.3.1. RISE IN GENOME TECHNOLOGY
4.4. CHALLENGES
4.4.1. IMPLEMENTATION OF MIQE GUIDELINES FOR PUBLISHING DPCR-BASED RESEARCH
4.4.2. INCREASING AVAILABILITY OF ALTERNATIVE TECHNOLOGIES
5. POLYMERASE CHAIN REACTION MARKET BY TECHNOLOGY
5.1. DIGITAL PCR (DPCR)
5.2. QUANTITATIVE PCR (QPCR)
6. MARKET SEGMENTATION
6.1. MARKET BY PRODUCT AND SERVICES 2017-2025
6.1.1. INSTRUMENTS
6.1.2. REAGENTS & CONSUMABLES
6.1.3. SOFTWARE & SERVICES
6.2. MARKET BY APPLICATION 2017-2025
6.2.1. CLINICAL
6.2.2. RESEARCH
6.2.3. FORENSIC
6.3. MARKET BY END USER 2017-2025
6.3.1. RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
6.3.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
6.3.3. CLINICAL RESEARCH ORGANISATION
6.3.4. FORENSIC LABORATORIES
7. KEY ANALYTICAL
7.1. KEY MARKET INSIGHTS
7.1.1. FAST GROWING COUNTRIES
7.1.2. MARKET TRENDS
7.2. OPPORTUNITY MATRIX
7.3. VENDOR LANDSCAPE
8. GEOGRAPHIC ANALYSIS
8.1. EUROPE
8.1.1. UNITED KINGDOM
8.1.2. FRANCE
8.1.3. GERMANY
8.1.4. SPAIN
8.1.5. REST OF EUROPE
9. COMPANY PROFILES
9.1. COMPETITIVE LANDSCAPE
9.1.1. MARKET SHARE ANALYSIS
9.1.2. TOP WINNING STRATEGIES
9.2. AFFYMETRIX, INC.
9.3. AGILENT TECHNOLOGIES, INC.
9.4. BIOMERIEUX S.A.
9.5. BIO-RAD LABORATORIES, INC.
9.6. F. HOFFMAN-LA ROCHE LTD
9.7. FLUIDIGM CORPORATION
9.8. GENNOVA SCIENTIFIC SL
9.9. MDX HEALTH
9.10. NANOBIOSYS INC.
9.11. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
9.12. QIAGEN N.V
9.13. RAINDANCE TECHNOLOGIES, INC. (ACQUIRED BY BIO-RAD LABORATORIES, INC)
9.14. TAKARA BIO, INC.
9.15. THERMO FISHER SCIENTIFIC INC
9.16. Z-BIOMED INC
9.17. STRATEGIC RECOMMENDATION & CONCLUSION
TABLE LIST
TABLE 1 EUROPE DIGITAL PCR MARKET 2017-2025 ($MILLION)
TABLE 3 PRICES OF QPCR VS DPCR DEVICES
TABLE 4 EUROPE DIGITAL PCR MARKET BY PRODUCT AND SERVICES 2017-2025 ($MILLION)
TABLE 5 EUROPE INSTRUMENTS MARKET 2017-2025 ($MIILION)
TABLE 6 EUROPE REAGENTS AND CONSUMABLE MARKET 2017-2025($MILLION)
TABLE 7 EUROPE SOFTWARE & SERVICES MARKET 2017-2025 ($MILLION)
TABLE 8 EUROPE DIGITAL PCR MARKET BY APPLICATION 2017-2025 ($MILLION)
TABLE 9 EUROPE DPCR CLINICAL APPLICATION MARKET 2017-2025 ($MILLION)
TABLE 10 EUROPE RESEARCH MARKET 2017-2025 ($MILLION)
TABLE 11 EUROPE FORENSIC MARKET 2017-2025 ($MILLION)
TABLE 12 EUROPE DIGITAL PCR MARKET BY END USER 2017-2025 ($MILLION)
TABLE 13 EUROPE RESEARCH LABORATORY AND ACADEMIC INTITUTES MARKET 2017-2025 ($MILLION)
TABLE 14 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2017-2025 ($MILLION)
TABLE 15 EUROPE CLINICAL RESEARCH ORGANISATIONS MARKET ($2017-2025)
TABLE 16 EUROPE FORENSIC LABORATOTY MARKET 2017-2025 ($MILLION)
FIGURES LIST
FIGURE 1 NUMBER OF CANCER CASES AROUND THE WORLD (IN MILLION)
FIGURE 2 INCIDENCES OF PEOPLE WITH HIV
FIGURE 3 NUMBER OF HOSPITALS (2015)
FIGURE 4 EUROPE INSTRUMENT MARKET 2017-2025 ($MILLION)
FIGURE 5 EUROPE REAGENTS & CONSUMABLES MARKET 2017-2025 ($MILLION)
FIGURE 6 EUROPE SOFTWARE & SERVICES MARKET 2017-2025 ($MILLION)
FIGURE 7 EUROPE CLINICAL MARKET 2017-2025 ($MILLION)
FIGURE 8 EUROPE RESEARCH MARKET 2017-2025 ($MILLION)
FIGURE 9 EUROPE FORENSIC MARKET 2017-2025 ($MILLION)
FIGURE 10 EUROPE RESEARCH LABORATORY AND ACADEMIC INTITUTES MARKET 2017-2025 ($MILLION)
FIGURE 11 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES MARKET 2017-2025 ($MILLION)
FIGURE 12 EUROPE CLINICAL RESEARCH ORGANIZATION MARKET 2017-2025 ($MILLION)
FIGURE 13 EUROPE FORENSIC LABORATORIES MARKET 2017-2025 ($MILLION)
FIGURE 14 GROWTH OF THE COUNTRIES CAGR FOR THE FORECASTED PERIOD 2017-2025
FIGURE 15 EUROPE DIGITAL PCR MARKET
FIGURE 16 UNITED KINGDOM (UK) DIGITAL PCR MARKET 2017-2025 ($MILLION)
FIGURE 17 EUROPE MEN AND WOMEN CANCER MORTALITY 2016
FIGURE 18 GERMANY DIGITAL PCR MARKET 2017-2025 ($MILLION)
FIGURE 19 SPAIN DIGITAL PCR MARKET 2017-2025 ($MILLION) FIGURE 32 REST OF EUROPE DIGITAL PCR MARKET 2017-2025 ($MILLION)
FIGURE 45 MARKET SHARE ANALYSIS OF KEY PLAYERS IN DIGITAL PCR MARKET 2016
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
4. MARKET DYNAMICS
4.1. DRIVERS
4.1.1. INCREASING INCIDENTS OF INFECTIOUS DISEASES AND GENETIC DISORDERS
4.1.2. INCREASING ELDERLY POPULATION
4.1.3. RISING GERIATRIC POPULATION
4.1.4. INCREASING PUBLIC–PRIVATE INVESTMENTS AND GRANTS
4.1.5. RISE IN THE NUMBER OF HOSPITALS AND DIAGNOSTICS CENTERS
4.2. RESTRAINTS
4.2.1. HIGH DEVICE COSTS ASSOCIATED WITH DPCR
4.2.2. NEED TO TRAINING AND UPDATATION OF LABORATORIES WORKERS
4.3. OPPORTUNITIES
4.3.1. RISE IN GENOME TECHNOLOGY
4.4. CHALLENGES
4.4.1. IMPLEMENTATION OF MIQE GUIDELINES FOR PUBLISHING DPCR-BASED RESEARCH
4.4.2. INCREASING AVAILABILITY OF ALTERNATIVE TECHNOLOGIES
5. POLYMERASE CHAIN REACTION MARKET BY TECHNOLOGY
5.1. DIGITAL PCR (DPCR)
5.2. QUANTITATIVE PCR (QPCR)
6. MARKET SEGMENTATION
6.1. MARKET BY PRODUCT AND SERVICES 2017-2025
6.1.1. INSTRUMENTS
6.1.2. REAGENTS & CONSUMABLES
6.1.3. SOFTWARE & SERVICES
6.2. MARKET BY APPLICATION 2017-2025
6.2.1. CLINICAL
6.2.2. RESEARCH
6.2.3. FORENSIC
6.3. MARKET BY END USER 2017-2025
6.3.1. RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
6.3.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
6.3.3. CLINICAL RESEARCH ORGANISATION
6.3.4. FORENSIC LABORATORIES
7. KEY ANALYTICAL
7.1. KEY MARKET INSIGHTS
7.1.1. FAST GROWING COUNTRIES
7.1.2. MARKET TRENDS
7.2. OPPORTUNITY MATRIX
7.3. VENDOR LANDSCAPE
8. GEOGRAPHIC ANALYSIS
8.1. EUROPE
8.1.1. UNITED KINGDOM
8.1.2. FRANCE
8.1.3. GERMANY
8.1.4. SPAIN
8.1.5. REST OF EUROPE
9. COMPANY PROFILES
9.1. COMPETITIVE LANDSCAPE
9.1.1. MARKET SHARE ANALYSIS
9.1.2. TOP WINNING STRATEGIES
9.2. AFFYMETRIX, INC.
9.3. AGILENT TECHNOLOGIES, INC.
9.4. BIOMERIEUX S.A.
9.5. BIO-RAD LABORATORIES, INC.
9.6. F. HOFFMAN-LA ROCHE LTD
9.7. FLUIDIGM CORPORATION
9.8. GENNOVA SCIENTIFIC SL
9.9. MDX HEALTH
9.10. NANOBIOSYS INC.
9.11. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
9.12. QIAGEN N.V
9.13. RAINDANCE TECHNOLOGIES, INC. (ACQUIRED BY BIO-RAD LABORATORIES, INC)
9.14. TAKARA BIO, INC.
9.15. THERMO FISHER SCIENTIFIC INC
9.16. Z-BIOMED INC
9.17. STRATEGIC RECOMMENDATION & CONCLUSION
TABLE LIST
TABLE 1 EUROPE DIGITAL PCR MARKET 2017-2025 ($MILLION)
TABLE 3 PRICES OF QPCR VS DPCR DEVICES
TABLE 4 EUROPE DIGITAL PCR MARKET BY PRODUCT AND SERVICES 2017-2025 ($MILLION)
TABLE 5 EUROPE INSTRUMENTS MARKET 2017-2025 ($MIILION)
TABLE 6 EUROPE REAGENTS AND CONSUMABLE MARKET 2017-2025($MILLION)
TABLE 7 EUROPE SOFTWARE & SERVICES MARKET 2017-2025 ($MILLION)
TABLE 8 EUROPE DIGITAL PCR MARKET BY APPLICATION 2017-2025 ($MILLION)
TABLE 9 EUROPE DPCR CLINICAL APPLICATION MARKET 2017-2025 ($MILLION)
TABLE 10 EUROPE RESEARCH MARKET 2017-2025 ($MILLION)
TABLE 11 EUROPE FORENSIC MARKET 2017-2025 ($MILLION)
TABLE 12 EUROPE DIGITAL PCR MARKET BY END USER 2017-2025 ($MILLION)
TABLE 13 EUROPE RESEARCH LABORATORY AND ACADEMIC INTITUTES MARKET 2017-2025 ($MILLION)
TABLE 14 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2017-2025 ($MILLION)
TABLE 15 EUROPE CLINICAL RESEARCH ORGANISATIONS MARKET ($2017-2025)
TABLE 16 EUROPE FORENSIC LABORATOTY MARKET 2017-2025 ($MILLION)
FIGURES LIST
FIGURE 1 NUMBER OF CANCER CASES AROUND THE WORLD (IN MILLION)
FIGURE 2 INCIDENCES OF PEOPLE WITH HIV
FIGURE 3 NUMBER OF HOSPITALS (2015)
FIGURE 4 EUROPE INSTRUMENT MARKET 2017-2025 ($MILLION)
FIGURE 5 EUROPE REAGENTS & CONSUMABLES MARKET 2017-2025 ($MILLION)
FIGURE 6 EUROPE SOFTWARE & SERVICES MARKET 2017-2025 ($MILLION)
FIGURE 7 EUROPE CLINICAL MARKET 2017-2025 ($MILLION)
FIGURE 8 EUROPE RESEARCH MARKET 2017-2025 ($MILLION)
FIGURE 9 EUROPE FORENSIC MARKET 2017-2025 ($MILLION)
FIGURE 10 EUROPE RESEARCH LABORATORY AND ACADEMIC INTITUTES MARKET 2017-2025 ($MILLION)
FIGURE 11 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES MARKET 2017-2025 ($MILLION)
FIGURE 12 EUROPE CLINICAL RESEARCH ORGANIZATION MARKET 2017-2025 ($MILLION)
FIGURE 13 EUROPE FORENSIC LABORATORIES MARKET 2017-2025 ($MILLION)
FIGURE 14 GROWTH OF THE COUNTRIES CAGR FOR THE FORECASTED PERIOD 2017-2025
FIGURE 15 EUROPE DIGITAL PCR MARKET
FIGURE 16 UNITED KINGDOM (UK) DIGITAL PCR MARKET 2017-2025 ($MILLION)
FIGURE 17 EUROPE MEN AND WOMEN CANCER MORTALITY 2016
FIGURE 18 GERMANY DIGITAL PCR MARKET 2017-2025 ($MILLION)
FIGURE 19 SPAIN DIGITAL PCR MARKET 2017-2025 ($MILLION) FIGURE 32 REST OF EUROPE DIGITAL PCR MARKET 2017-2025 ($MILLION)
FIGURE 45 MARKET SHARE ANALYSIS OF KEY PLAYERS IN DIGITAL PCR MARKET 2016
